RxDoctor Payments Data

Bruce Decotiis

Allergy & Immunology · Brick, NJNPI 1750494613

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,365 of the $37,517 with a category attached, or 80.9%. 29 manufacturers reported payments, led by Sanofi at 46.5% of the total. Reporting peaked in 2019 at $18,162 and has fallen 98.2% since, to $325 in 2025. Among allergy & immunology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,517in general payments, 2019–2025

Across 321 payments — averaging $116.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$17K
  • Genentech USA, Inc.$11K
  • Regeneron Healthcare Solutions, Inc.$5K
  • AstraZeneca$1K
  • GSK$523
  • Amgen$373
  • plus $3K from 23 others
$609,821in research payments, 2019–2025

Across 123 payments — averaging $4957.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$251K
  • GSK$166K
  • Chiesi USA, Inc.$71K
  • Hikma Pharmaceuticals USA$64K
  • Regeneron$24K
  • Novartis$16K
  • plus $20K from 3 others

What the payments were for

  • Consulting fees$200%
  • Speaking & faculty fees$30,36581%
  • Travel & lodging$7552%
  • Food & beverage$6,34817%
  • Education$290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,517 in reported general payments places this provider in the 90th percentile of 135 allergy & immunology providers in New Jersey.

See all allergy & immunology providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Arnuity ElliptaFluticasone Furoate13$4,037
Montelukast Sodium37$593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArnuity Ellipta$523$4,03713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 135 allergy & immunology providers in New Jersey.

Other allergy & immunology in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →